High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...
MUSC expands gene therapy, resources for Sickle Cell ‘warriors’ in South Carolina
The Medical University of South Carolina is expanding its access to state-supported Sickle Cell programs for “warriors,” or ...
The Nation Newspaper3d
Not all sickle cell patients need bone marrow transplants – SCFN
National Director of the Sickle Cell Foundation Nigeria (SCFN), Dr. Annette Akinsete, has said that despite advancements in the treatment of sickle cell disease, not every patient requires a bone ...
Yahoo Finance3d
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (GLOBE NEWSWIRE) -- The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using CRISPR ...
St. Louis American5d
Wash U student study explores sickle cell impact on thinking
In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...
Morningstar2d
Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US
This marks the first successful treatment of its kind outside the ... Casgevy (exagamglogene autotemcel), to sickle cell disorder and beta thalassaemia patients from all over the globe.